BioSpace News Archive

According to Emergen Research, the global cerebrospinal fluid management market size was USD 1.50 billion in 2020 and is expected to reach USD 2.09 billion in 2028 and register a revenue CAGR of 4.5% during the forecast period, 2021-2028.

According to Emergen Research, the global diabetic care market size was USD 22.70 billion in 2019 and is expected to reach USD 41.71 billion in 2027 and register a revenue CAGR of 7.9% during the forecast period, 2021-2028.

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

The industry analysis report is considered a valuable source of information about the global Vaginal Pessary industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

The American Diabetes Association® released its diabetes 2021 Research Report showcasing extraordinary discoveries in the U.S. With over 200 grants currently being managed, the organization’s goal is to use research to improve the lives of the 133 million Americans living with diabetes and prediabetes.

Premium manufacturer of chromatography for proteomics applications, IonOpticks, has entered an OEM partnership with the Bruker Corporation, allowing Bruker to expand their portfolio of 4D-Proteomics solutions with the release of the Bruker Focus Series columns which will leverage the technology of IonOpticks’ revolutionary Aurora Series columns.

AB Science SA announced that Professor Olivier Hermine, President of the Scientific Committee of AB Science, will deliver a presentation on the amyotrophic lateral sclerosis masitinib development program to an audience of key opinion leaders and decision-makers in the field of ALS research and healthcare policy, at the up-coming ALS Drug Development Summit in Boston, USA.

Blue Eye Soft is excited to announce that the U.S. Patent Office has officially awarded a utility patent for the company’s artificial intelligence (AI) technology which powers a clinical decision support tool that analyzes chest x-rays to more rapidly detect COVID-19, and other illness such as cancer, developing in lungs.

Avalo Therapeutics, Inc. announced that members of its senior management team will present and host 1x1 meetings at the 2022 BIO CEO and Investor Conference being held at the Marriott Marquis in NYC on February 14-15, 2022 and virtually through February 17, 2022.